Why Both Weight Management Injections Matter for UK Patients
What Is Wegovy and How Does It Compare to Mounjaro?
Understanding what Wegovy is requires comparing it directly to Mounjaro, as both represent the latest generation of weight management injections available in the UK. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro uses tirzepatide, which targets both GLP-1 and GIP receptors, creating what researchers call a "dual incretin" approach to weight management. Both are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity.
The key difference lies in their receptor targeting mechanisms and dosing schedules. Wegovy follows a 5-dose escalation protocol from 0.25mg to 2.4mg maintenance over 17 weeks, while Mounjaro uses 6 doses ranging from 2.5mg to 15mg. Neither treatment should be considered superior without clinical context — your prescriber at EverydayMeds can assess which mechanism aligns better with your medical history and treatment goals. Both medications require careful dose escalation and ongoing medical supervision.
Wegovy vs Mounjaro Pricing: What Is the Real Cost Difference?
When researching what Wegovy is versus Mounjaro, pricing transparency becomes crucial for UK patients planning long-term treatment. Our Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Mounjaro pricing follows a different structure reflecting its distinct dosing schedule, but both treatments offer bundle options for treatment continuity.
Our unique position supplying both treatments means you can compare equivalent treatment phases without switching pharmacies. The Intro Duo bundle (0.25mg and 0.5mg Wegovy) costs £169.99, covering your first 8 weeks of treatment with convenient single delivery. For maintenance therapy, our Ultimate Stability Trio provides three 2.4mg pens for £649.99, ensuring uninterrupted supply. Bundle pricing focuses on convenience rather than savings — fewer orders, Reliable Supply continuity, and simplified medication management during your weight management journey.
Clinical Evidence: What Is Wegovy's Trial Data vs Mounjaro?
The STEP clinical trial programme demonstrates what Wegovy is capable of achieving in controlled conditions. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 data showed sustained clinically studied weight loss maintained at 2 years, while the SELECT cardiovascular outcomes trial reported a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials show different percentage outcomes, but direct comparison isn't clinically meaningful due to varying trial designs, patient populations, and study durations. Both treatments demonstrated significant weight management support in their respective trials when used as part of comprehensive lifestyle interventions. Your EverydayMeds prescriber considers individual factors rather than trial averages when recommending between these options.
How Wegovy Works: Understanding What Is Different About GLP-1
Explaining what Wegovy is requires understanding its GLP-1 receptor agonist mechanism, which differs fundamentally from Mounjaro's dual-receptor approach. Wegovy mimics glucagon-like peptide-1, a hormone naturally released by your intestines after eating that signals fullness to your brain's appetite centres. This mechanism may help reduce food cravings, promote earlier satiety during meals, and support portion control as part of your overall weight management strategy. The once-weekly injection maintains consistent hormone levels, potentially supporting appetite regulation between doses. Unlike stimulant-based weight management approaches, Wegovy works through your body's existing satiety pathways rather than artificially suppressing appetite.
Ordering Process: What Is Required for Wegovy vs Mounjaro Access
Both Wegovy and Mounjaro require identical ordering processes through EverydayMeds, reflecting their prescription-only status and MHRA regulations. Our 3-minute online clinical assessment captures essential medical history, current medications, previous weight management attempts, and relevant health conditions that might influence treatment choice. Your responses undergo review by our prescribing team within 3 working days (or 24 hours with express service), who determine both your eligibility and the most appropriate treatment option. Once approved, both medications ship via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transport. This standardised process ensures consistent care standards whether you're prescribed Wegovy, Mounjaro, or switching between treatments during your weight management journey.
Storage and Practical Considerations: What Is Wegovy's Advantage
Understanding what Wegovy is includes recognising its practical storage advantages over Mounjaro for UK patients with active lifestyles. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration. Mounjaro's room temperature stability extends only 21 days, making Wegovy more suitable for extended travel, work trips, or situations where refrigeration access might be interrupted. The FlexTouch pen delivery system used by Wegovy offers familiar injection mechanics for patients previously using other Novo Nordisk medications, while both treatments require proper needle disposal following each weekly injection. This storage flexibility can be particularly valuable during the 17+ week treatment period required for full dose escalation.
What Is the Strategic Advantage of Dual-Treatment Access?
Few UK pharmacies offer both Wegovy and Mounjaro, making EverydayMeds' dual availability strategically valuable for patients researching what Wegovy is compared to alternatives. This unique position allows treatment switching if initial medication choice proves unsuitable, without changing pharmacy providers or repeating registration processes. Your prescriber can recommend Wegovy's GLP-1 mechanism for patients with specific medical profiles, then switch to Mounjaro's dual incretin approach if clinical response suggests better suitability.
Our clinical team's experience with both treatments enables informed comparisons based on individual patient factors rather than generic recommendations. This flexibility becomes particularly valuable during the dose escalation phases, where individual tolerance and response patterns may favour one mechanism over another. Having both options available through a single GPhC-registered pharmacy (#9012878) ensures continuity of care and consistent clinical oversight throughout your weight management journey.
Making Your Decision: What Is Right for Your Circumstances
Rather than asking what Wegovy is versus whether it's "better" than Mounjaro, focus on which mechanism aligns with your medical profile and lifestyle requirements. Our clinical assessment captures factors like previous GLP-1 experience, diabetes status, cardiovascular risk factors, and storage/travel needs that influence treatment selection. Both medications require identical commitment levels — weekly injections, dose escalation protocols, dietary modifications, and regular monitoring — but their different mechanisms may suit different patient profiles. Your EverydayMeds prescriber weighs these individual factors against each treatment's clinical profile to recommend the most appropriate option.
Starting your assessment today provides access to both treatments through our established supply chains and clinical protocols. Use code FIRST40 for new customers or DOSE25 for returning patients at checkout, with both discount codes applied to reach our published pricing structure. Whether you begin with Wegovy or Mounjaro, our ongoing clinical support ensures optimal treatment outcomes throughout your weight management programme.
Begin your clinical assessment for both Wegovy and Mounjaro treatment options through our secure online platform.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
